VIVO Cannabis Inc. VVCIF

ALEF on it's way up, 0.60, dont need psychic powers to see..

[Schaffhausen]

VIVO's most relevant comparison is ALEF, with strikingly similar business models, revenues, operational costs, etc. The BIG difference at this point in time is Market Cap, with ALEF more than double, almost triple the cap of VIVO. ALEF and VIVO have historically tracked very close in SP movements. You dont need to be psychic to see where VIVO is going. Cheers, Schaff

[srtman03]

Vivo has always done more revenue then Alefia Q over Q....so what are we looking at for Vivo's Q1??? Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14.6M Net Revenue in Q1 2020 Wednesday, May 13, 2020, 7:00 AM ET Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14.6M Net Revenue in Q1 2020 -- $13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486

[Kinglou64]

VIVO 8.2M Positive Adjusted EBITDA Q1 

[Prizm3000]

Idiot pumpers. There's a reason the enterprise value of Alefea is more than 4 times that of VIVO: they actually produce pot. Barry put the brakes on expansion and essentially shrunk the company. Their revenues have been pretty flat since legalization, so I'd be surprised if they manage to break $8M in revenue with $0 ebitda. SG&A is already very high for such a tiny operation, and now,

[Schaffhausen]

If there is another company that could see a 183% increase in revenue, its VIVO. VIVO and ALEF had similar revenues coming into Q1 and a similar medical and C2.0 business model. Note that the ALEF revenue increase was undoubtedly known or leaked into the market, with the bought deal financing on the go, and was priced into ALEFs meteoric 120% shareprice increase over the last two weeks. That's

[Kinglou64]

Looks like I nailed it 8.2 million